ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers

A Study to Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in Adults

ClinicalTrials.gov ID: NCT06890416

Public ClinicalTrials.gov record NCT06890416. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 7:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 3, MULTICENTER, PARALLEL-GROUP, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE WHEN COADMINISTERED WITH HERPES ZOSTER SUBUNIT VACCINE IN ADULTS ≥50 YEARS OF AGE

Study identification

NCT ID
NCT06890416
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
526 participants

Conditions and interventions

Interventions

  • HZ/su VACCINE Biological
  • RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE Biological

Biological

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 3, 2025
Primary completion
Sep 29, 2025
Completion
Sep 29, 2025
Last update posted
Nov 5, 2025

2025

United States locations

U.S. sites
25
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
Central Research Associates Birmingham Alabama 35205
Medical Affiliated Research Center Huntsville Alabama 35801
AMR Clinical Mobile Alabama 36608
Kaiser Permanente Los Angeles California 90027
Diablo Clinical Research, Inc. Walnut Creek California 94598
Alliance for Multispecialty Research, LLC Doral Florida 33172
Proactive Clinical Research,LLC Fort Lauderdale Florida 33308
De La Cruz Research Center, LLC Miami Florida 33184
Centricity Research Columbus Georgia Multispecialty Columbus Georgia 31904
Clinical Research Atlanta Stockbridge Georgia 30281
Synexus Clinical Research US, Inc. Chicago Illinois 60602
Optimal Research Peoria Illinois 61614
DelRicht Research New Orleans Louisiana 70115
Jadestone Clinical Research Silver Spring Maryland 20904
Oakland Medical Research Troy Michigan 48085
Clinical Research Professionals Chesterfield Missouri 63005
IMA Clinical Research Warren Warren Township New Jersey 07059
NYU Langone Health New York New York 10016
Centricity Research Columbus Ohio Multispecialty Columbus Ohio 43213
DM Clinical Research - Philadelphia Philadelphia Pennsylvania 19107
Clinical Neuroscience Solutions Inc. Memphis Tennessee 38119
DM Clinical Research - Bellaire Houston Texas 77081
SMS Clinical Research Mesquite Texas 75149
IMA Clinical Research San Antonio San Antonio Texas 78229
DM Clinical Research - Sugar Land Sugar Land Texas 77478

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06890416, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 5, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06890416 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →